JX-594 and prostate cancer — some follow-up

There has been considerable interest in yesterday’s news item about JX-594 and its potential applicability to the treatment of prostate cancer, so we have done a little more homework.

Might JX-594 have significant clinical activity in prostate cancer?

Data just published in the journal Nature suggest that an engineered oncolytic virus called JX-594 selectively targeted and destroyed cancer cells in patients without significantly affecting healthy tissue.

Follow

Get every new post delivered to your Inbox.

Join 269 other followers